16th Annual Geriatrics and Long-term Care Update,Sunday, September 27, 2015 Survey

	Strongly Agree	Agree	Neutral	Disagree	Strongly Disagree
Explain the practice of Specialty Pharmacy as a novel trend in medicine including locally available specialty pharmacy services.	Explain the practice of Specialty Pharmacy as a novel trend in medicine including locally available specialty pharmacy services. Strongly Agree	Explain the practice of Specialty Pharmacy as a novel trend in medicine including locally available specialty pharmacy services. Agree	Explain the practice of Specialty Pharmacy as a novel trend in medicine including locally available specialty pharmacy services. Neutral	Explain the practice of Specialty Pharmacy as a novel trend in medicine including locally available specialty pharmacy services. Disagree	Explain the practice of Specialty Pharmacy as a novel trend in medicine including locally available specialty pharmacy services. Strongly Disagree
Explain the value of working in interprofessional teams to mitigate the impact of substance abuse problems in older adults.	Explain the value of working in interprofessional teams to mitigate the impact of substance abuse problems in older adults. Strongly Agree	Explain the value of working in interprofessional teams to mitigate the impact of substance abuse problems in older adults. Agree	Explain the value of working in interprofessional teams to mitigate the impact of substance abuse problems in older adults. Neutral	Explain the value of working in interprofessional teams to mitigate the impact of substance abuse problems in older adults. Disagree	Explain the value of working in interprofessional teams to mitigate the impact of substance abuse problems in older adults. Strongly Disagree
Identify the role the updated Beers Criteria play in reducing adverse drug events in older adults.	Identify the role the updated Beers Criteria play in reducing adverse drug events in older adults. Strongly Agree	Identify the role the updated Beers Criteria play in reducing adverse drug events in older adults. Agree	Identify the role the updated Beers Criteria play in reducing adverse drug events in older adults. Neutral	Identify the role the updated Beers Criteria play in reducing adverse drug events in older adults. Disagree	Identify the role the updated Beers Criteria play in reducing adverse drug events in older adults. Strongly Disagree
Discuss strategies for utilizing pharmacogenomic profiling to target pain management therapy for a particular patient.	Discuss strategies for utilizing pharmacogenomic profiling to target pain management therapy for a particular patient. Strongly Agree	Discuss strategies for utilizing pharmacogenomic profiling to target pain management therapy for a particular patient. Agree	Discuss strategies for utilizing pharmacogenomic profiling to target pain management therapy for a particular patient. Neutral	Discuss strategies for utilizing pharmacogenomic profiling to target pain management therapy for a particular patient. Disagree	Discuss strategies for utilizing pharmacogenomic profiling to target pain management therapy for a particular patient. Strongly Disagree
Discuss common antimicrobial stewardship strategies.	Discuss common antimicrobial stewardship strategies. Strongly Agree	Discuss common antimicrobial stewardship strategies. Agree	Discuss common antimicrobial stewardship strategies. Neutral	Discuss common antimicrobial stewardship strategies. Disagree	Discuss common antimicrobial stewardship strategies. Strongly Disagree
Identify special considerations for customizing pharmacotherapeutic interventions in geriatric patients.	Identify special considerations for customizing pharmacotherapeutic interventions in geriatric patients. Strongly Agree	Identify special considerations for customizing pharmacotherapeutic interventions in geriatric patients. Agree	Identify special considerations for customizing pharmacotherapeutic interventions in geriatric patients. Neutral	Identify special considerations for customizing pharmacotherapeutic interventions in geriatric patients. Disagree	Identify special considerations for customizing pharmacotherapeutic interventions in geriatric patients. Strongly Disagree

Strongly Agree

Agree

Neutral

Disagree

Strongly Disagree

Explain the practice of Specialty Pharmacy as a novel trend in medicine including locally available specialty pharmacy services.

Explain the practice of Specialty Pharmacy as a novel trend in medicine including locally available specialty pharmacy services. Strongly Agree

Explain the practice of Specialty Pharmacy as a novel trend in medicine including locally available specialty pharmacy services. Agree

Explain the practice of Specialty Pharmacy as a novel trend in medicine including locally available specialty pharmacy services. Neutral

Explain the practice of Specialty Pharmacy as a novel trend in medicine including locally available specialty pharmacy services. Disagree

Explain the practice of Specialty Pharmacy as a novel trend in medicine including locally available specialty pharmacy services. Strongly Disagree

Explain the value of working in interprofessional teams to mitigate the impact of substance abuse problems in older adults.

Explain the value of working in interprofessional teams to mitigate the impact of substance abuse problems in older adults. Strongly Agree

Explain the value of working in interprofessional teams to mitigate the impact of substance abuse problems in older adults. Agree

Explain the value of working in interprofessional teams to mitigate the impact of substance abuse problems in older adults. Neutral

Explain the value of working in interprofessional teams to mitigate the impact of substance abuse problems in older adults. Disagree

Explain the value of working in interprofessional teams to mitigate the impact of substance abuse problems in older adults. Strongly Disagree

Identify the role the updated Beers Criteria play in reducing adverse drug events in older adults.

Identify the role the updated Beers Criteria play in reducing adverse drug events in older adults. Strongly Agree

Identify the role the updated Beers Criteria play in reducing adverse drug events in older adults. Agree

Identify the role the updated Beers Criteria play in reducing adverse drug events in older adults. Neutral

Identify the role the updated Beers Criteria play in reducing adverse drug events in older adults. Disagree

Identify the role the updated Beers Criteria play in reducing adverse drug events in older adults. Strongly Disagree

Discuss strategies for utilizing pharmacogenomic profiling to target pain management therapy for a particular patient.

Discuss strategies for utilizing pharmacogenomic profiling to target pain management therapy for a particular patient. Strongly Agree

Discuss strategies for utilizing pharmacogenomic profiling to target pain management therapy for a particular patient. Agree

Discuss strategies for utilizing pharmacogenomic profiling to target pain management therapy for a particular patient. Neutral

Discuss strategies for utilizing pharmacogenomic profiling to target pain management therapy for a particular patient. Disagree

Discuss strategies for utilizing pharmacogenomic profiling to target pain management therapy for a particular patient. Strongly Disagree

Discuss common antimicrobial stewardship strategies.

Discuss common antimicrobial stewardship strategies. Strongly Agree

Discuss common antimicrobial stewardship strategies. Agree

Discuss common antimicrobial stewardship strategies. Neutral

Discuss common antimicrobial stewardship strategies. Disagree

Discuss common antimicrobial stewardship strategies. Strongly Disagree

Identify special considerations for customizing pharmacotherapeutic interventions in geriatric patients.

Identify special considerations for customizing pharmacotherapeutic interventions in geriatric patients. Strongly Agree

Identify special considerations for customizing pharmacotherapeutic interventions in geriatric patients. Agree

Identify special considerations for customizing pharmacotherapeutic interventions in geriatric patients. Neutral

Identify special considerations for customizing pharmacotherapeutic interventions in geriatric patients. Disagree

Identify special considerations for customizing pharmacotherapeutic interventions in geriatric patients. Strongly Disagree

	Yes	No	No Change
This activity increased my knowledge.	This activity increased my knowledge. Yes	This activity increased my knowledge. No	This activity increased my knowledge. No Change
If "Yes", please describe
This activity increased my competence.	This activity increased my competence. Yes	This activity increased my competence. No	This activity increased my competence. No Change
If "Yes", please describe
This activity will improve my performance.	This activity will improve my performance. Yes	This activity will improve my performance. No	This activity will improve my performance. No Change
If "Yes", please describe
This activity will improve my patients' outcome.	This activity will improve my patients' outcome. Yes	This activity will improve my patients' outcome. No	This activity will improve my patients' outcome. No Change
If "Yes", please describe

Yes

No Change

This activity increased my knowledge.

This activity increased my knowledge. Yes

This activity increased my knowledge. No

This activity increased my knowledge. No Change

If "Yes", please describe

This activity increased my competence.

This activity increased my competence. Yes

This activity increased my competence. No

This activity increased my competence. No Change

If "Yes", please describe

This activity will improve my performance.

This activity will improve my performance. Yes

This activity will improve my performance. No

This activity will improve my performance. No Change

If "Yes", please describe

This activity will improve my patients' outcome.

This activity will improve my patients' outcome. Yes

This activity will improve my patients' outcome. No

This activity will improve my patients' outcome. No Change

If "Yes", please describe

Question Title

* 4. Do you feel the activity was scientifically sound and free of commercial bias or influence?

Yes

If "No", please explain

Question Title

* 5. Please identify how you will change your practice as a result of attending this activity.

This activity validated my current practice; no changes will be made

Change the management and/or treatment of my patients.

Create/revise protocols, policies, and/or procedures.

Other (please specify)

Question Title

* 6. Please indicate any barriers you perceive in implementing these changes.

Cost

Lack of opportunity

Lack of administrative support

Lack of experience

Lack of consensus or professional guidelines

Lack of resources

Lack of time to assess/counsel patients

Reimbursement/insurance issues

Patient compliance issues

No barriers

Other (please specify)

Question Title

* 7. Will you attempt to address these barriers in order to implement changes in your competence, performance and/or patients' outcomes.

N/A

Yes

If "Yes", how? and If "No", why not?

Question Title

* 8. How might the format of this activity be improved for the content presented?

Format was appropriate, no changes needed.

Include more case-based presentations

Increase interactivity with attendees

Add breakouts for subtopics

Add a hands-on instructional component

Schedule more time for Q & A

Other (please specify)

Question Title

* 9. The content of this activity matched my current (or potential) scope of practice.

Yes

If "No", please explain.

Question Title

* 10. Please list suggestions for topics you would like to learn more about in future educational activities.

Question Title

* 11. How did you find out about this activity?

UAMS Website

UAMS Announcements

Received a fax

Email Announcement

Postcard

From a Friend/colleague

16th Annual Geriatrics and Long-term Care Update,Sunday, September 27, 2015

Overall Evaluation, Sunday, September 27, 2015

Question Title

* 1. Professional Degree ( Check all that apply)

Question Title

* 2. Please rate the impact of the following overall objectives

Question Title

* 3. Please rate projected impact of this activity on your knowledge, competence, performance, and patients' outcomes.

Question Title

* 4. Do you feel the activity was scientifically sound and free of commercial bias or influence?

Question Title

* 5. Please identify how you will change your practice as a result of attending this activity.

Question Title

* 6. Please indicate any barriers you perceive in implementing these changes.

Question Title

* 7. Will you attempt to address these barriers in order to implement changes in your competence, performance and/or patients' outcomes.

Question Title

* 8. How might the format of this activity be improved for the content presented?

Question Title

* 9. The content of this activity matched my current (or potential) scope of practice.

Question Title

* 10. Please list suggestions for topics you would like to learn more about in future educational activities.

Question Title

* 11. How did you find out about this activity?